Spiegel K - Search Results

1

PD 90780, a non peptide inhibitor of nerve growth factor's binding to the P75 NGF receptor.

Spiegel K, Agrafiotis D, Caprathe B, Davis RE, Dickerson MR, Fergus JH, Hepburn TW, Marks JS, Van Dorf M, Wieland DM, et al. Spiegel K, et al. Biochem Biophys Res Commun. 1995 Dec 14;217(2):488-94. doi: 10.1006/bbrc.1995.2802. Biochem Biophys Res Commun. 1995. PMID: 7503726

2

Kynurenic acid derivatives inhibit the binding of nerve growth factor (NGF) to the low-affinity p75 NGF receptor.

Jaen JC, Laborde E, Bucsh RA, Caprathe BW, Sorenson RJ, Fergus J, Spiegel K, Marks J, Dickerson MR, Davis RE. Jaen JC, et al. Among authors: spiegel k. J Med Chem. 1995 Oct 27;38(22):4439-45. doi: 10.1021/jm00022a008. J Med Chem. 1995. PMID: 7473570

3

Therapeutic intervention in dementia.

Davis RE, Emmerling MR, Jaen JC, Moos WH, Spiegel K. Davis RE, et al. Among authors: spiegel k. Crit Rev Neurobiol. 1993;7(1):41-83. Crit Rev Neurobiol. 1993. PMID: 8096799 Review.

4

CI-1017, a functionally M1-selective muscarinic agonist: design, synthesis, and preclinical pharmacology.

Tecle H, Schwarz RD, Barrett SD, Callahan MJ, Caprathe BW, Davis RE, Doyle P, Emmerling M, Lauffer DJ, Mirzadegan T, Moreland DW, Lipiniski W, Nelson C, Raby C, Spencer C, Spiegel K, Thomas AJ, Jaen JC. Tecle H, et al. Among authors: spiegel k. Pharm Acta Helv. 2000 Mar;74(2-3):141-8. doi: 10.1016/s0031-6865(99)00027-8. Pharm Acta Helv. 2000. PMID: 10812951

5

Traumatic brain injury elevates the Alzheimer's amyloid peptide A beta 42 in human CSF. A possible role for nerve cell injury.

Emmerling MR, Morganti-Kossmann MC, Kossmann T, Stahel PF, Watson MD, Evans LM, Mehta PD, Spiegel K, Kuo YM, Roher AE, Raby CA. Emmerling MR, et al. Among authors: spiegel k. Ann N Y Acad Sci. 2000 Apr;903:118-22. doi: 10.1111/j.1749-6632.2000.tb06357.x. Ann N Y Acad Sci. 2000. PMID: 10818496

6

Inhibiting the formation of classical C3-convertase on the Alzheimer's beta-amyloid peptide.

Emmerling MR, Spiegel K, Watson MD. Emmerling MR, et al. Among authors: spiegel k. Immunopharmacology. 1997 Dec;38(1-2):101-9. doi: 10.1016/s0162-3109(97)00067-2. Immunopharmacology. 1997. PMID: 9476121

7

The role of complement in Alzheimer's disease pathology.

Emmerling MR, Watson MD, Raby CA, Spiegel K. Emmerling MR, et al. Among authors: spiegel k. Biochim Biophys Acta. 2000 Jul 26;1502(1):158-71. doi: 10.1016/s0925-4439(00)00042-9. Biochim Biophys Acta. 2000. PMID: 10899441 Free article. Review.

8

Traumatic brain injury increases beta-amyloid peptide 1-42 in cerebrospinal fluid.

Raby CA, Morganti-Kossmann MC, Kossmann T, Stahel PF, Watson MD, Evans LM, Mehta PD, Spiegel K, Kuo YM, Roher AE, Emmerling MR. Raby CA, et al. Among authors: spiegel k. J Neurochem. 1998 Dec;71(6):2505-9. doi: 10.1046/j.1471-4159.1998.71062505.x. J Neurochem. 1998. PMID: 9832149 Free article.

9

The cholinergic deficit coincides with Abeta deposition at the earliest histopathologic stages of Alzheimer disease.

Beach TG, Kuo YM, Spiegel K, Emmerling MR, Sue LI, Kokjohn K, Roher AE. Beach TG, et al. Among authors: spiegel k. J Neuropathol Exp Neurol. 2000 Apr;59(4):308-13. doi: 10.1093/jnen/59.4.308. J Neuropathol Exp Neurol. 2000. PMID: 10759186

10

Sleep as a mediator of the relationship between socioeconomic status and health: a hypothesis.

Van Cauter E, Spiegel K. Van Cauter E, et al. Among authors: spiegel k. Ann N Y Acad Sci. 1999;896:254-61. doi: 10.1111/j.1749-6632.1999.tb08120.x. Ann N Y Acad Sci. 1999. PMID: 10681902

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

140 results

Search Page

Filters